IB NEURO™
Dynamic susceptibility contrast (DSC) MRI methods allow the creation of relative cerebral blood volume (rCBV) maps that have the potential to provide more specific information about brain tumor biology and vasculature than compared to standard anatomical MR images. It has been shown that MRI-derived rCBV may: 1) better differentiate histologic brain tumor types than conventional MRI; 2) provide information to predict glial tumor grade; and 3) provide key insights for helping predict survival. In addition, rCBV maps may aid in differentiating post-treatment radiation effects from tumor and predict local recurrence or malignant transformation earlier than conventional anatomical MR imaging.